Galectin Therapeutics Inc.

GALT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$15,120$25,660$18,592$39,648
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,132$2,050$1,960$2,172
Total Curr. Assets$17,252$27,710$20,552$41,820
Property Plant & Equip (Net)$0$53$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$243$437$733$7
Total NC Assets$243$490$733$7
Other Assets$0$0$0$0
Total Assets$17,495$28,200$21,285$41,827
Liabilities
Payables$5,656$6,431$3,890$1,805
Short-Term Debt$21,136$46$40$8
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8,617$9,199$9,082$7,220
Total Curr. Liab.$35,409$15,676$13,012$9,033
LT Debt$85,109$71,761$39,828$29,048
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$47$1,004$639$1,130
Total NC Liab.$85,156$72,765$40,467$30,178
Other Liabilities$0$0$0$0
Cap. Leases$19$66$40$8
Total Liabilities$120,565$88,441$53,479$39,211
Equity
Pref Stock$2,223$2,223$2,233$2,250
Common Stock$62$61$59$59
Retained Earnings-$401,572-$354,372-$309,567-$270,694
AOCI$0$0$0$0
Other Equity$296,217$291,847$275,081$271,001
Total Equity-$103,070-$60,241-$32,194$2,616
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$17,495$28,200$21,285$41,827
Net Debt$91,125$46,147$21,276-$10,592